Keyword

blepharospasm

Description: A focal dystonia involving involuntary, forceful contractions of the muscles that control eyelid closure and blinking.

Primary topic: Botulinum Toxin and Related Neurological Disorders (50%)

Wikidata ID: wiki/Q883863

OpenAlex ID: keywords/blepharospasm

Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]

2016 · David M. Simpson, Mark Hallett, et al. · Neurology · 620

PDF

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]

2008 · D. M. Simpson, A. Blitzer, et al. · Neurology · 618

PDF

Botulinum A toxin for cranial‐cervical dystonia

1987 · Joseph Jankovic, Janet Orman · Neurology · 553

Cervical dystonia

1991 · Joseph Jankovic, Stuart Leder, et al. · Neurology · 424

Botulinum A Toxin Injection as a Treatment for Blepharospasm

1985 · A. B. Scott, R. A. Kennedy, et al. · Archives of Ophthalmology · 419

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm

1987 · Mitchell F. Brin, Stanley Fahn, et al. · Movement Disorders · 417

Pathophysiology of Blepharospasm and Oromandibular Dystonia

1985 · A. BERARDELLI, J. C. ROTHWELL, et al. · Brain · 409

Movement disorders following lesions of the thalamus or subthalamic region

1994 · M. S. Lee, C. D. Marsden · Movement Disorders · 395

A prevalence study of primary dystonia in eight European countries

2000 · Not Available Not Available · Journal of Neurology · 379

Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

2005 · Timothy R. Coté, Aparna K. Mohan, et al. · Journal of the American Academy of Dermatology · 362

Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.

1990 · J Jankovic, K Schwartz, et al. · Journal of Neurology Neurosurgery & Psychiatry · 353

PDF

Therapy—botulinum Toxin

2002 · CRC Press eBooks · 346

Blepharospasm: a review of 264 patients.

1988 · F Grandas, J Elston, et al. · Journal of Neurology Neurosurgery & Psychiatry · 339

PDF

Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patients

1983 · Joseph Jankovic, Janet Ford · Annals of Neurology · 318

Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration

1987 · H. Miyajima, Y. Nishimura, et al. · Neurology · 295

Ophthalmologic features of Parkinson’s disease

2004 · V. Biousse, B. C. Skibell, et al. · Neurology · 277

Autoimmune post–herpes simplex encephalitis of adults and teenagers

2015 · Thaís Armangue, Germán Moris, et al. · Neurology · 273

PDF

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders

2013 · Mark Hallett, Alberto Albanese, et al. · Toxicon · 272

Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?

1976 · C D Marsden · Journal of Neurology Neurosurgery & Psychiatry · 254

PDF

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

2005 · P. Roggenkämper, W. H. Jost, et al. · Journal of Neural Transmission · 246

Drug-Induced Ocular Disorders

2008 · Junping Li, Ramesh C Tripathi, et al. · Drug Safety · 226

Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia

1997 · Joel S. Perlmutter, Mikula K. Stambuk, et al. · Journal of Neuroscience · 223

PDF

Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice

2016 · Francesco Scaglione · Toxins · 216

PDF

DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

1997 · Cristina Sampaio, Joaquim J. Ferreira, et al. · Movement Disorders · 207

Long‐term efficacy of botulinum toxin A in treatment of various movement disorders over a 10‐year period

2002 · G‐Y.R. Hsiung, S.K. Das, et al. · Movement Disorders · 204

Works count: 3,895

Citation count: 53,170